Breast cancer surgery - Historical evolution, current status and future perspectives

Acta Oncologica

Volumn 40, Issue 1, 2001, Pages 5-18

  Sakorafas, G H ^a  

^a NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; BIOPSY; CHEMOTHERAPY; TUMORS;

BREAST CONSERVATION THERAPY; MASTECTOMY;

SURGERY;

ANTINEOPLASTIC AGENT; HORMONE;

AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; BREAST RECONSTRUCTION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CYTOTOXICITY; DIAGNOSTIC IMAGING; HISTORY OF MEDICINE; HORMONAL THERAPY; HUMAN; LYMPH NODE DISSECTION; MAMMOGRAPHY; MASTECTOMY; META ANALYSIS; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE;

BIOPSY, NEEDLE; BREAST NEOPLASMS; FEMALE; FORECASTING; HUMANS; LYMPH NODE EXCISION; MAMMAPLASTY; MASTECTOMY; MASTECTOMY, RADICAL;

EID: 0035075518     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418601750070984     Document Type: Review

References (220)

1. Cancer statistics, 1997
2. Estimates of the world-wide incidence of eighteen major cancer in 1985
3. Estimates of the worldwide incidence of eighteen major cancers - 1985. Implications for prevention and projections of future burden
4. The history of breast cancer surgery: Early beginning to Halsted
5. History of breast disease and its treatment
6. Treatment of breast cancer through the ages
7. A conceptual history of cancer
8. Development of modern breast cancer treatment
9. The surgical treatment of breast cancer: An historical and collective review
10. On the average duration of life in patients with scirrhous cancer of the breast
11. Elements of breast surgery with notes by Samuel D. Gross
12. On the influence of inadequate operations on the theory of cancer
13. Zur Behandlung des Brustkrebses
14. The results of operations for the cure of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894
15. The results of operations for the cure of cancer of the pancreas performed at the Johns Hopkins Hospitals
16. A clinical and histological study of certain adenocarcinoma of the breast; and a brief consideration of the superclavicular operation and of results of the operations for cancer of the breast from 1889-1898 at the Johns Hopkins Hospital
17. An improved method of the radical operation for carcinoma of the breast
18. The results of radical operations for the cure of carcinoma of the breast
19. A study of results - Johns Hopkins Hospital, 1889-1931
20. The prognosis of carcinoma of the breast in relation to the type of operation performed
21. Significance of location and number of axillary metastases in carcinoma of the breast: A justification for a conservative operation
22. Modified radical mastectomy
23. Radical versus modified radical mastectomy for breast cancer
24. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients
25. The treatment of primary carcinoma of the breast with radium
26. Conservative treatment of cancer of the breast
27. Treatment of breast cancer by tumor extirpation and roentgen therapy instead of radical operation
28. Treatment of breast cancer by local excision
29. Treatment of early breast cancer: A report after ten years of a clinical trial
30. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
31. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
32. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer
33. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute Trials
34. Factors influencing local relapse and survival and results of salvage management after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer
35. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer: EORTC 10801 trial
36. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis
37. Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data
38. Effects of radiotherapy and surgery in early breast cancer
39. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave-Roussy 1970-1982)
40. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy
41. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: A nonrandomized comparison
42. Ten years results of conservative surgery and irradiation for stage I and II breast cancer
43. Conservative treatment of early breast cancer: Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy
44. Long-term outcome following breast conserving surgery and radiation therapy
45. Age is a prognostic factor for breast and regional node recurrence following breast conserving surgery and irradiation in stage I and II breast cancer
46. Treatment of early-stage breast cancer
47. Breast-conserving surgery for breast cancer: Patterns of care in a geographic region and estimation of potential applicability
48. Changing trends in the diagnosis and treatment of early breast cancer
49. Breast-conserving treatment: Controversies and consensus
50. Risk factors in breast-conservation therapy
51. Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy
52. Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data
53. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer
54. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer
55. What have we learned about risk factors for local recurrence after breast-conserving surgery and irradiation?
56. Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy
57. Analysis of local-regional relapses in patients with early breast cancers treated with excision and radiotherapy: Experience of the institute Gustave-Roussy
58. Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer
59. A clinical and histopathological analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma
60. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control
61. Quadrantectomy versus lumpectomy for small size breast cancer
62. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy
63. Results of re-excisional biopsy of the primary tumor in preparation for definitive irradiation of patients with early stage breast cancer
64. Breast relapse following primary radiation therapy for early breast cancer. 1. Classification, frequency, and salvage
65. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy
66. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early breast carcinoma
67. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively
68. Segmental mastectomy without radiotherapy: Short-term follow-up
69. Pathological findings from the National Adjuvant Breast Project (Protocol 6). II. Relation of local breast recurrence to multicentricity
70. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy
71. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer
72. Alternative strategies in the management of primary breast cancer
73. Local failure and margin status in early-stage breast carcinoma treated with conservative surgery and radiation therapy
74. The relationship between microscopic margins of resection and the risk of local recurrence in breast cancer patients treated with conservative surgery and radiation therapy
75. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer
76. Recurrence in the breast following treatment of patients with early stage breast cancer with conservative surgery and radiation therapy
77. The second ten years: Long-term risks of breast conservation in early breast cancer
78. Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radio-therapy
79. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up
80. Optimal management of primary breast cancer
81. Invasive breast cancer
82. Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial
83. Radiotherapy after breast-conserving surgery in women with localized cancer of the breast
84. Histologic multi-focality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery
85. Multicentricity and bilaterality in invasive breast cancer
86. Breast cancer. Experiences with conservative surgery
87. Conservative surgery and radiation therapy for early breast cancer: Results, controversies, and unresolved problems
88. The impact of tumor size and histology on local control after breast conserving therapy
89. Breast reconstruction following lumpectomy and irradiation
90. Post-mastectomy breast deformities: Classification and techniques of surgical correction
91. Partial mastectomy: Technical considerations in achieving cosmesis
92. Immediate transposition of a latissimus dorsi muscle for correcting a quadrantectomy breast deformity in Japanese patients
93. Oncologic and cosmetic outcome in patients with breast cancer related with wide excision, transposition of adipose tissue with latissimus dorsi muscle, and axillary dissection followed by radiotherapy
94. Endoscopic mastectomy and reconstruction: Endoscopic breast surgery
95. Endoscopic assisted transaxillary augmentation mammoplasty
96. Selection of patients with early stage invasive breast cancer for treatment with conservative surgery and radiation therapy
97. Standards for breast-conservation treatment
98. Consequences of breast irradiation in patients with pre-existing collagen vascular disease
99. Breast conservation therapy: Severe breast fibrosis after radiation therapy in patient with collagen-vascular disease
100. Acute and late reactions to radiation therapy in patients with collagen vascular diseases
101. Identification of a subgroup of patients with breast cancer in whom conservative surgery and radiation is contraindicated
102. Intraductal carcinoma of the breast: Results of treatment with excisional biopsy and irradiation
103. Significance of ipsilateral breast tumor recurrence after lumpectomy
104. Randomized controlled trial of conservative therapy for breast cancer: 6-years analysis of the Scottish trial
105. Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy
106. Breast tumor recurrence following lumpectomy with and without breast irradiation: An overview of recent NSABP findings
107. Segmental mastectomy without radiotherapy for T1 and small T2 breast carcinomas
108. Factors affecting recurrence in lumpectomy without irradiation for breast cancer
109. Can we identify patients with invasive breast cancer adequately treated with breast-conserving surgery alone?
110. Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer
111. Geographic differences in treatment of early stage breast cancer
112. Locally advanced noninflammatory breast cancer
113. Combined modality treatment of stage III and inflammatory breast cancer: MD Anderson experience
114. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma
115. Locally advanced breast cancer: Defining an optimum treatment regimen
116. Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast
117. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
118. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more
119. Response to induction chemotherapy for breast cancer: A prospective multimodality treatment program
120. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm
121. Conservation surgery after primary chemotherapy in large carcinomas of the breast
122. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer
123. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: The University of Michigan experience
124. Meeting highlights: International consensus panel on the treatment of primary breast cancer
125. Patient benefits from new treatment options and schedules for breast cancer
126. Psychological problems of adjustment to cancer of the breast
127. A 6-year experience with immediate reconstruction after mastectomy for cancer
128. Changing trends in postmastectomy breast reconstruction: A 13-year experience
129. Recurrence of breast carcinoma following immediate reconstruction: A 13-year review
130. Immediate versus delayed reconstruction
131. Reconstruction and the radiated breast: Is there a role for implants?
132. Breast reconstruction
133. Latissimus dorsi myocutaneous flap for breast reconstruction: Long-term results
134. Reconstructive breast surgery
135. Breast reconstruction by superior gluteal microvascular free flaps without silicone implants
136. The inferior gluteal free flap in breast reconstruction
137. Immediate breast reconstruction: Why the free TRAM over the conventional TRAM flap?
138. The free transverse rectus abdominis musculocutaneous flap for breast reconstruction: One center's experience with 211 consecutive cases
139. Nipple-areola reconstruction
140. The use of intradermal tattoo to enhance the final result of nipple-areola reconstruction
141. Transaxillary endoscopic partial mastectomy for comparatively early-stage breast cancer; an earlier experience
142. Transaxillary approach for the endoscopic extirpation of benign breast tumors
143. Early experience of endoscopic extirpation of benign breast tumors via an extra-mammary incision
144. Axillary lymphadenectomy by lipo-aspiration and endoscopic picking. Apropos of 72 cases
145. Endoscopic exploration and lymph node sampling of the axilla. Preliminary findings of a randomized pilot study comparing clinical and anatomo-pathologic results of endoscopic axillary lymph node sampling with traditional surgical treatment
146. Endoscopic axillary exploration and sentinel lymphadenectomy
147. Subcutaneous endoscopic plastic surgery using a retractor mounted endoscopic system
148. The endoscopic breast augmentation: The trans-umbilical insertion of saline-filled breast implants
149. Minimally invasive harvesting of rectus abdominis myofascial flap in the cadaver and porcine models
150. Endoscopic augmentation mammoplasty: The umbilical approach
151. Interstitial laser hyperthermia model development for minimally invasive therapy of breast carcinoma
152. Stereotactic uses beyond core biopsy; model development for minimally invasive treatment of breast cancer through interstitial laser hyperthermia
153. A theoretical comparison of energy sources-microwave, ultrasound and laser - For interstitial thermal therapy
154. Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies
155. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: Data from a phase III trial
156. Nd:YAG interstitial laser thermotherapy in the treatment of breast cancer
157. Cryosurgery of breast cancer
158. Conservative surgery in breast cancer
159. Fine-needle aspiration in the management of breast masses
160. Diagnostic accuracy, cost-effectiveness, and triage role of fine-needle aspiration biopsy in the diagnosis of palpable breast lesions
161. Needle aspiration biopsy: Past, present, and future
162. Inter-institutional comparison of performance in breast fine-needle aspiration cytology
163. Fine-needle aspiration of the breast: Diagnostic problems and approaches to surgical management
164. Fine needle aspiration
165. Fine-needle aspiration versus core needle biopsy For diagnosis of nonpalpable and palpable breast lesions
166. Evaluation of common breast problems: Guidance for primary care providers
167. Percutaneous large core breast biopsy
168. Large-gauge core needle biopsy of the breast
169. Stereotactic core needle biopsy
170. Ultrasound-guided fine needle aspiration cytology of nonpalpable breast lesions: Diagnostic categories and their likelihood of benign and malignant findings
171. Stereotactic fine-needle aspiration biopsy For the evaluation of nonpalpable breast lesions: Report of an experience based on 2988 cases
172. Stereotactic core biopsy of breast carcinoma: Accuracy at predicting invasion
173. Initial experience with the advanced breast biopsy instrumentation system
174. Breast biopsies with ABBI: Experience with 183 attempted biopsies
175. Mammographic localization of unexpected breast cancer
176. A modified needle hookwire to simplify preoperative localization of occult breast lesions
177. Wire localized biopsy of breast lesions: A review of 425 cases found in screening or clinical mammography
178. Proper placement of a metallic marker on an area of concern in the breast
179. Radio-guided surgery of occult breast lesions
180. Use of radioimmunoguided surgery after induction chemotherapy in locally advanced breast cancer
181. Sentinel lymph node biopsy in breast cancer
182. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
183. The need to reexamine axillary lymph node dissection in invasive breast cancer
184. Axillary lymph nodes and breast cancer. A review
185. The impact of prophlylactic axillary lymph node dissection on breast cancer survival: A bayesian meta-analysis
186. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-18
187. Management of the axilla in breast cancer - Implication for diagnosis, prognosis, treatment and morbidity
188. Axillary surgery in breast cancer management - Background, incidence and extent of nodal spread, extent of surgery and accurate axillary staging, surgical procedures
189. Axillary lymph node dissection in breast cancer, Current status and controversies, alternative strategies and future perspectives
190. Relation of tumor size, lymph node status, and survival in 214 740 breast cancer patients
191. Controversies in the treatment of ductal carcinoma in situ
192. In situ carcinoma of the breast
193. Tubular carcinoma of the breast: Clinical and pathological observations concerning 135 cases
194. Impact of axillary dissection on staging and regional control in breast tumors < 10 mm-the DBCG experience
195. How American oncologists treat breast cancer: An assessment of the influence of clinical trials
196. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
197. Impact of axillary lymph node dissection on the therapy of breast cancer patients
198. Breast disease in elderly women
199. Meeting highlight: International consensus panel on treatment of primary breast cancer
200. Adjuvant chemotherapy plus tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival
201. Technical details of intraoperative lymphatic mapping for early stage melanoma
202. Minimal-access surgery for staging of malignant melanoma
203. Lymphoscintigraphy, the sentinel node concept and the intraoperative gamma probe in melanoma, breast cancer and other potential cancers
204. Sentinel node biopsy in breast cancer
205. Improved axillary staging of breast cancer with sentinel lymphadenectomy
206. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative nodes
207. Lymphatic mapping and sentinel lymph node biopsy in the patient with breast cancer
208. Intradermal blue dye to identify sentinel lymph-node in breast cancer
209. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
210. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
211. Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
212. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary lymph node dissection?
213. Sentinel node localization in breast cancer patients using intradermal dye injection